Avanti Polar Lipids Becomes Avanti Research, a Croda Brand

Avanti Polar Lipids, a global leader in lipids, recently announced its renewed offering for researchers and its transformation to Avanti Research. This marks another exciting chapter in the company’s evolution, underscoring its commitment to innovation and expanding its portfolio for researchers worldwide enhancing access to research-grade lipids, polymers, and tools for delivery development.

In 2020, Avanti Polar Lipids was acquired by Croda, the company that uses smart science to create technologies that improve lives. The acquisition brought together Avanti’s expertise in lipid-based drug delivery solutions and Croda’s range of pharmaceutical excipients and cGMP manufacturing capabilities. Now, four years on, the Avanti Polar Lipids brand continues to expand and reinforces its commitment to the research community, with refreshed take on the renowned logo and brand name.

David Cherry, Interim President Life Sciences, said “We are driven by our Purpose, to use smart science to improve lives, and recognise the importance of effectively serving our research community to achieve this. This is an exciting change representing our expanded vision to provide researchers with a more comprehensive range of lipids, ingredients, and tools to investigate the fundamentals of human biology and develop the next generation of therapeutic delivery systems.”

Kyle Black, Sales and Marketing Manager, added “The evolution to Avanti Research as a Croda brand is a significant milestone in our journey. We’ve gathered invaluable feedback from our customers and teams, and becoming Avanti Research is a direct reflection of our shared aspirations. It’s not just a name; it’s a commitment to delivering more value to researchers and building on our strong foundation to drive progress and serve the scientific community for years to come.”

A series of new initiatives will be unveiled by Avanti Research in the coming months, to further expand the brands offering and to enhance its support for customers. This includes new product lines, partnerships and enhanced benefits, such as discounts for academic and non-profit organizations, discontinuation of the credit card fee and an enhanced online purchasing experience.

The Avanti Research brand honors a rich history of lipid innovation while embracing the future as a part of Croda, with expanded GMP capabilities and more solutions to offer academic, biotech and pharma researchers. For more information, visit www.avantiresearch.com.

Avanti Research (formerly Avanti Polar Lipids) was founded in 1967 to meet the demand for highly purified lipids in scientific research. Over the decades, these lipids have built a world-renowned reputation. Now a part of the Croda family, the Avanti Research brand leads the way with the highly purified lipids, ingredients and services for pharmaceutical and fundamental research, and diagnostics. With a catalogue boasting over 2,000 lipids, Avanti Research also offers custom lipid synthesis and formulation development.

Croda’s Pharma business is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations, committed to enabling the next generation of drug delivery systems. The business is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid, delivery platforms.